Register Cart 0

Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back Subscribe

Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

Author(s): Hans Carl Hasselbalch

Volume 12, Issue 3, 2011

Page: [387 - 391] Pages: 5

DOI: 10.2174/138945011794815220

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

28

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets

Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry

Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective
Anti-Cancer Agents in Medicinal Chemistry

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Current Cancer Drug Targets

Ligand-Targeted Liposomes for Cancer Treatment
Current Drug Delivery

The Use of Therapeutic Peptides to Target and to Kill Cancer Cells
Current Medicinal Chemistry

Targeted Drugs and Nanomedicine: Present and Future
Current Pharmaceutical Design

ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design

The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism

Treatment of Acute Hypercalcemia
Medicinal Chemistry

Synthesis, Docking and Anti-Tumor Activity of β-L-1,3-Thiazolidine Pyrimidine Nucleoside Analogues
Medicinal Chemistry

Fractal Analysis of the Bone Marrow in Myelodysplastic Syndromes
Current Bioinformatics

CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy
Current Drug Metabolism

Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application
Current Gene Therapy

Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs
Cardiovascular & Hematological Disorders-Drug Targets

Anti-VEGF Strategies – from Antibodies to Tyrosine Kinase Inhibitors: Background and Clinical Development in Human Cancer
Current Pharmaceutical Design

Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS
Current Cancer Therapy Reviews

Issues in the Psychiatric Screening of Cancer Patients
Current Psychiatry Reviews

Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity
Current Cancer Drug Targets

Mikuliczs Disease and its Extraglandular Lesions
Current Immunology Reviews (Discontinued)

© 2024 Bentham Science Publishers | Privacy Policy